Magnetic resonance examination to predict pathological complete response following neoadjuvant chemotherapy: when is it appropriate for HER2-positive and triple-negative breast cancers?
about
Magnetic resonance examination to predict pathological complete response following neoadjuvant chemotherapy: when is it appropriate for HER2-positive and triple-negative breast cancers?
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Magnetic resonance examination ...... riple-negative breast cancers?
@en
Magnetic resonance examination ...... riple-negative breast cancers?
@nl
type
label
Magnetic resonance examination ...... riple-negative breast cancers?
@en
Magnetic resonance examination ...... riple-negative breast cancers?
@nl
prefLabel
Magnetic resonance examination ...... riple-negative breast cancers?
@en
Magnetic resonance examination ...... riple-negative breast cancers?
@nl
P2093
P2860
P1433
P1476
Magnetic resonance examination ...... riple-negative breast cancers?
@en
P2093
Koichiro Tsugawa
Satoko Okamoto
Takayuki Yamada
Yasuo Nakajima
Yasuyuki Kojima
Yoshihide Kanemaki
P2860
P2888
P304
P356
10.1007/S12282-015-0642-7
P577
2015-10-05T00:00:00Z